The Beauty Health Company
SKIN
$0.8458
-$0.0141-1.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -16.00% | -12.94% | -6.26% | 4.35% | 8.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.00% | -12.94% | -6.26% | 4.35% | 8.78% |
| Cost of Revenue | -37.42% | -23.01% | 73.09% | 95.40% | 107.42% |
| Gross Profit | 17.52% | -0.16% | -50.99% | -40.73% | -37.65% |
| SG&A Expenses | -11.65% | -12.72% | -9.03% | -1.17% | 3.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.98% | -17.05% | 18.19% | 29.03% | 35.02% |
| Operating Income | 48.23% | 31.33% | -274.60% | -348.21% | -406.63% |
| Income Before Tax | 71.00% | 69.50% | -351.09% | -526.83% | -324.73% |
| Income Tax Expenses | 74.51% | 149.15% | 141.31% | 123.83% | -259.01% |
| Earnings from Continuing Operations | 70.94% | 66.53% | -701.47% | -975.25% | -326.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.94% | 66.53% | -701.47% | -975.25% | -326.38% |
| EBIT | 48.23% | 31.33% | -274.60% | -348.21% | -406.63% |
| EBITDA | 64.57% | 50.31% | -1,111.59% | -1,720.38% | -3,142.65% |
| EPS Basic | 69.02% | 64.71% | -681.83% | -846.81% | -354.13% |
| Normalized Basic EPS | 53.13% | 49.44% | -478.24% | -521.56% | -364.79% |
| EPS Diluted | 43.74% | 38.59% | -425.60% | -191.58% | -240.90% |
| Normalized Diluted EPS | 55.59% | 52.29% | -463.65% | -518.07% | -367.89% |
| Average Basic Shares Outstanding | -5.97% | -6.83% | -8.24% | -9.56% | -10.77% |
| Average Diluted Shares Outstanding | 1.54% | 0.55% | -1.21% | -6.09% | -11.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |